Projects & Funding (Current and Completed)
Active Grants
09/01/2018 – 07/31/2023 |
Long-term metabolic effects of kidney events with intensive SBP control Principal Investigator: Srinivasan Beddhu Role: Principal Investigator |
05/15/2021 – 04/30/2026 | Sit Less, Interact and Move More (SLIMM) 2
Principal Investigator: Srinivasan Beddhu 1R01DK128640 Role: Principal Investigator |
07/15/2021 – 03/31/2026 |
Objectively Measured Sedentary Behavior and Physical Activity in PREVENTABLE Study Principal Investigator: Srinivasan Beddhu 1R01AG074592-01 Role: Principal Investigator |
08/01/2021 – 07/31/2025 |
Remote Monitoring and Virtual Collaborate Care for Hypertension Control to Prevent Cognitive Decline Principal Investigators: Jeffrey Burns, Aditi Gupta, Russell Waitman 4R33AG068483-02 Role: Site Principal Investigator |
10/2021 – 09/2023 |
Racial and Ethnic Disparities in Renal Replacement Therapy in Rural Veterans Principal Investigator: Srinivasan Beddhu VA ORH-14398 Role: Principal Investigator |
6/1/2021- |
Pentoxifylline in Diabetic Kidney Disease (PTXRx) Principal Investigator: David J. Leehey VA CSP-2008 Role: Site Principal Investigator |
Past NIH/ AHRQ Grants
08/01/1999 - 05/30/2002 | The HEMO Study Utah Clinical Site National Institutes of Health Role: Co-Principal Investigator of the site |
05/01/2001 - 04/30/2003 | Comorbidity, Costs and Outcomes in Dialysis Patients. The major goal of this project was to develop an ESRD specific comorbidity index Principal Investigator: Srinivasan Beddhu Direct Costs: $66,500 Total Costs: $99,750 Agency for Healthcare Research and Quality Role: Principal Investigator |
09/10/2007 - 08/31/2012 |
Protein Intake, Nutrition, and cardiovascular disease in CKD Stage V Principal Investigator: Srinivasan Beddhu |
08/01/2008 - 04/30/2012 |
Adipokines In Hemodialysis Patients Principal Investigator: Srinivasan Beddhu |
06/01/2011 - 05/31/2018 |
SPRINT – Factors Affecting Atherosclerosis Study (FAST) R01 DK091437 National Institute of Diabetes and Digestive and Kidney Diseases Direct Costs: $1,729,984 Total Costs: $2,287,297 |
09/01/2011 - 08/31/2015 |
Role: Principal Investigator Pulse Wave Velocity and Central Aortic Pressure Outcomes in SPRINT |
09/14/2009 - 08/30/2018 | Systolic Blood Pressure Intervention Trial (SPRINT) Clinical Center Networks Principal Investigator: Alfred K. Cheung Direct Costs: $1,386,886 Total Costs: $1,840,397 HHSN268200900046C, National Heart, Lung, and Blood Institute Role: Co-Investigator |
11/15/2016 – 06/30/2019 |
Sit Less, Interact, Move More (SLIMM) Intervention for Sedentary Behavior in CKD National Institutes of Health |